BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26817443)

  • 1. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
    Kühn T; Floegel A; Sookthai D; Johnson T; Rolle-Kampczyk U; Otto W; von Bergen M; Boeing H; Kaaks R
    BMC Med; 2016 Jan; 14():13. PubMed ID: 26817443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
    BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity.
    Bagheri M; Farzadfar F; Qi L; Yekaninejad MS; Chamari M; Zeleznik OA; Kalantar Z; Ebrahimi Z; Sheidaie A; Koletzko B; Uhl O; Djazayery A
    J Proteome Res; 2018 Apr; 17(4):1452-1462. PubMed ID: 29493238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
    Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
    Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective analysis of circulating metabolites and endometrial cancer risk.
    Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
    Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of circulating metabolites and breast cancer in EPIC.
    His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
    BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
    Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
    Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
    BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium.
    Geijsen AJMR; van Roekel EH; van Duijnhoven FJB; Achaintre D; Bachleitner-Hofmann T; Baierl A; Bergmann MM; Boehm J; Bours MJL; Brenner H; Breukink SO; Brezina S; Chang-Claude J; Herpel E; de Wilt JHW; Gicquiau A; Gigic B; Gumpenberger T; Hansson BME; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Keski-Rahkonen P; Keulen ETP; Koole JL; Leeb G; Ose J; Schirmacher P; Schneider MA; Schrotz-King P; Stift A; Ulvik A; Vogelaar FJ; Wesselink E; van Zutphen M; Gsur A; Habermann N; Kampman E; Scalbert A; Ueland PM; Ulrich AB; Ulrich CM; Weijenberg MP; Kok DE
    Int J Cancer; 2020 Jun; 146(12):3256-3266. PubMed ID: 31495913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer.
    Uehara T; Kikuchi H; Miyazaki S; Iino I; Setoguchi T; Hiramatsu Y; Ohta M; Kamiya K; Morita Y; Tanaka H; Baba S; Hayasaka T; Setou M; Konno H
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S206-13. PubMed ID: 25752890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design.
    Cao B; Jin M; Brietzke E; McIntyre RS; Wang D; Rosenblat JD; Ragguett RM; Zhang C; Sun X; Rong C; Wang J
    Psychiatry Clin Neurosci; 2019 Mar; 73(3):100-108. PubMed ID: 30156046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
    Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
    Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
    Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V
    BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Stability of Human Plasma Metabolites during Storage at -80 °C.
    Haid M; Muschet C; Wahl S; Römisch-Margl W; Prehn C; Möller G; Adamski J
    J Proteome Res; 2018 Jan; 17(1):203-211. PubMed ID: 29064256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.